COL4A3 Gene Sequencing (Alport Syndrome, Autosomal Recessive) – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين COL4A3 لمتلازمة آلبورت المتنحية الجسدية – الفحص الجيني بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

يضمن اختبار تسلسل الجين COL4A3 عبر تقنيات الجيل التالي (NGS) دقة تشخيصية تصل إلى 99.9%، مع الامتثال الكامل لمعايير هيئة الصحة بدبي ولوائح الخصوصية بموجب قانون حماية البيانات الشخصية الإماراتي.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

The COL4A3 Genetic Test detects pathogenic variants in the COL4A3 gene responsible for autosomal recessive Alport Syndrome, a hereditary disorder affecting kidneys, ears, and eyes. This comprehensive sequencing offers definitive molecular diagnosis, guiding early clinical intervention and family planning. (يكشف تحليل جين COL4A3 عن الطفرات المسببة لمتلازمة آلبورت المتنحية ويوفر تشخيصًا جينيًا قاطعًا.)

Feature	Our COL4A3 NGS Test (UAE)	Closest Alternative
Precision	Full Gene Sequencing (all exons ±5 bp)	Targeted mutation panel (limited variants)
Method	NGS (Illumina platform) with orthogonal confirmation	Sanger sequencing or MLPA (partial coverage)
Turnaround	3–4 weeks (straightforward workflow)	6–8 weeks (fragmented outsourcing)

Physician Insight & Safety Protocol

Dr. PRABHAKAR REDDY (DHA License: 61713011): “As a clinician, I emphasize that a negative COL4A3 result does not exclude all hereditary nephropathies; a positive finding clarifies the molecular diagnosis, enabling timely renal surveillance and family screening. I encourage you to interpret this test in the context of your complete clinical picture and family history.”

⚕️ Clinical Reminder: Do not discontinue prescribed medication or alter your management plan without consulting your treating physician.

Safety Exclusion Criteria & ER Red Flags

Exclusion: This test is not indicated for individuals without a clinical suspicion of Alport syndrome or family history of COL4A3-associated disease; it is a diagnostic tool, not a screening assay for the general population.
ER Red Flag: If you experience sudden hearing loss, rapid decline in urine output, or acute visual disturbances, seek emergency care immediately—do not wait for genetic results.

Patient FAQ & Clinical Guidance

What is the clinical utility of the COL4A3 NGS test?

This test provides a definitive molecular diagnosis for autosomal recessive Alport syndrome by identifying pathogenic variants in the COL4A3 gene, enabling precise genetic counseling and early nephrology follow-up. (يُقدم هذا الفحص تشخيصًا جزيئيًا دقيقًا لمتلازمة آلبورت المتنحية من خلال تحديد الطفرات الممرضة في جين COL4A3، مما يسمح بالاستشارة الوراثية الدقيقة والمتابعة المبكرة لأمراض الكلى.)

How should I prepare for the sample collection?

A blood sample, extracted DNA, or a single blood drop on an FTA card is required; a genetic counseling session to document your family pedigree is strongly recommended before testing. (يلزم تقديم عينة دم أو حمض نووي مستخلص أو قطرة دم على بطاقة FTA، ويُنصح بشدة بإجراء جلسة استشارة وراثية لتوثيق شجرة العائلة قبل الفحص.)

Who should order this test and how are results reported?

General Physicians, Primary Care Doctors, or Medical & PhD Researchers can order this; results include ACMG-classified variants and a clinical interpretation aligned with DHA guidelines, delivered securely. (يمكن للأطباء العامين وأطباء الرعاية الأولية والباحثين الطبيين طلب هذا الفحص، وتشمل النتائج المتغيرات المصنفة وفقًا لمعايير ACMG مع تفسير سريري متوافق مع إرشادات هيئة الصحة بدبي.)

UAE Regulatory Compliance: Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Child Protection Law 2026, UAE Personal Data Protection Law (PDPL). All services rendered under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). DHA facility license: 9834453.

دعم ثنائي اللغة متاح